Newsfeeds - Spark Newswire

4 minute read

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More

Today, 5:41 AM

Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big pharma earnings. The sector came back up in the final session for a firm finish.

ABBV

3 minute read

6 Underperforming IPO Stocks To Buy On The Dip

By Wayne Duggan

Today, 5:41 AM

The U.S. IPO market was red-hot in 2021. The total number of traditional U.S. IPOs hit its highest level since the dot-com boom in the late 1990s, while total IPO deal value reached record levels last year.

FDMT

25 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 5:41 AM

During Friday's session, 445 companies made new 52-week lows.

AAOI

4 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 5:41 AM

On Wednesday, 41 stocks made new 52-week lows.

AVGR

2 minute read

The Daily Biotech Pulse: Glaukos Gets FDA Nod, Neurocrine Preannounces Soft Ingrezza Sales, 3 IPOs

By Shanthi Rexaline

Today, 5:41 AM

Here's a roundup of top developments in the biotech space over the last 24 hours.

AMLX

1 minute read

SVB Leerink Initiates Coverage On 4D Molecular Therapeutics with Outperform Rating, Announces Price Target of $30

By Benzinga Newsdesk

Today, 5:41 AM

SVB Leerink analyst Mani Foroohar initiates coverage on 4D Molecular Therapeutics (NASDAQ:FDMT) with a Outperform rating and announces Price Target of $30.

FDMT

5 minute read

66 Biggest Movers From Friday

By Lisa Levin

Today, 5:41 AM

Gainers Bakkt Holdings, Inc. (NASDAQ: BKKT) shares surged 66.1% to close at $42.52 on Friday on continued volatility after the company recently announced partnerships with Mastercard and Fiserv.

AAPL

4 minute read

44 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 5:41 AM

Gainers Guardforce AI Co., Limited (NASDAQ: GFAI) shares jumped 42% to $3.5350 after the company said it has engaged Int'l. Investor Relations Co., MZ Group, to lead strategic investor relations and financial communications program.

AAPL

4 minute read

The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs

By Shanthi Rexaline

Today, 5:41 AM

Here's a roundup of top developments in the biotech space over the last 24 hours.

2 minute read

4D Molecular Therapeutics Announces Proposed Public Offering Of 4.5M Shares Of Common Stock

By Benzinga Newsdesk

Today, 5:41 AM

4D Molecular Therapeutics (NASDAQ:FDMT), a clinical-stage gene therapy company harnessing the power of directed evolution for targeted gene therapies, announced today that it has commenced an underwritten public offering

FDMT